A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Abroad (travel likely)Recruiting
Conditions
Amyotrophic Lateral Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mass General Hospital -MGH, Boston, Massachusetts, United States
Contact: Principal Investigator (Alex Sherman)
Study leads
Medical Director
Study Director
Biogen